US abortion opponents want Trump's FDA to act on abortion pill restrictions
Louisiana officials want the FDA to curb telehealth access to mifepristone as the agency reviews safety data and considers new prescribing rules.
- On Tuesday, U.S. District Judge David Joseph declined to block telehealth access to mifepristone in a lawsuit brought by Louisiana Attorney General Liz Murrill, though he ordered the Food and Drug Administration to report on its safety review within six months.
- Murrill contends that online prescription access undermines abortion bans in 13 states, prompting anti-abortion groups to push the FDA to restrict telehealth prescribing and restore state-level restrictions.
- The FDA said Wednesday it is reviewing mifepristone safety, including data integrity and peer-review processes, while acknowledging the study could take a year or more but stating officials are attempting to move faster.
- Frustration has flared among anti-abortion activists, with Kristi Hamrick of Students for Life of America calling the administration's pace "beyond frustrating," while Health and Human Services Secretary Robert F. Kennedy Jr. confirmed the president requested a safety review.
- Since the 2022 Supreme Court ruling, abortion has appeared on the ballot in 17 states, with voters supporting abortion rights in 14 of those instances; experts suggest this indicates a public consensus that does not favor a total ban.
72 Articles
72 Articles
US abortion opponents want Trump’s FDA to act on abortion pill restrictions - Regional Media News
U.S. abortion opponents are increasingly frustrated with the lack of action by President Donald Trump's administration to stem the flow of abortion pills prescribed online that they view as undermining state abortion bans. A court ruling this week in a lawsuit the Louisiana attorney general brought against Trump's Food and Drug Administration cast a spotlight on the simmering tension. The judge said the state has a strong case while declining to…
Abortion Opponents Want Trump's FDA to Act on Abortion Pill Restrictions
Santa Maria Times
Abortion opponents in the United States are increasingly frustrated by the lack of action from President Donald Trump's administration to stem the flow of abortion pills prescribed online, which they see as undermining state bans…
Pittsburgh Post-Gazette
Los Angeles TimesU.S. abortion opponents want Trump's FDA to act on abortion pill restrictions
U.S. abortion opponents are increasingly frustrated with the lack of action by President Donald Trump's administration to stem the flow of abortion pills prescribed online that they view as undermining state abortion bans.
Coverage Details
Bias Distribution
- 77% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
